Search Results for keywords:"Rockledge Drive"

The National Institutes of Health is organizing several closed virtual meetings via the Center for Scientific Review. These meetings will occur from June 4 to June 11, 2025, and will focus on reviewing and evaluating grant applications across different specialized areas, such as neuroscience, vascular inflammation, and cancer therapeutics. The meetings are closed to the public to protect confidential information like trade secrets and personal data related to the grant applications. Each session is led by a Scientific Review Officer and is hosted at the NIH's Rockledge Drive location in Bethesda, but will take place virtually.

The National Institutes of Health announced a change to the meeting schedule of the Cancer Genetics Study Section. The meeting, originally set to start at 8:00 a.m. on February 22, 2021, will now start at 9:30 a.m., ending the next day at 5:00 p.m., but the location remains the same at Rockledge Drive, Bethesda, MD. This announcement was previously reported in the Federal Register on January 22, 2021, and the meeting remains closed to the public.

The National Institutes of Health has announced a change in the previously scheduled meeting for the Oncology 2—Translational Clinical Integrated Review Group. The meeting will take place from May 1 to May 2, 2025, at their Rockledge Drive location in Bethesda, Maryland. This amendment updates the contact for the Scientific Review Officer, replacing Lawrence Ka-Yun Ng with Victor Panchenko, Ph.D. The meeting is closed to the public.